Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.

Literature DB >> 6459767

In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.

V I Ahonkhai, C E Cherubin, M F Sierra, V D Bokkenheuser, M A Shulman, A C Mosenthal.

Abstract

The activities of 11 antimicrobial agents against 36 strains of Campylobacter fetus subsp. jejuni were studied by a broth microdilution method. All strains were susceptible to 7 of the 11 antimicrobial agents. Of the newer agents tested N-formimidoyl thienamycin (MK0787) and rosaramicin had very good activity, whereas cefotaxime, moxalactam, and cefoperazone had poorer activity.

Entities: Chemical Species

Mesh：

Substances：

Year: 1981 PMID： 6459767 PMCID： PMC181813 DOI： 10.1128/AAC.20.6.850

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

13 in total

1. Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.

Authors: J A Waitz; C G Drube; E L Moss; M J Weinstein
Journal: J Antibiot (Tokyo) Date: 1972-11 Impact factor: 2.649

2. Human infection by Vibrio fetus.

Authors: I A Cooper; K J Slee
Journal: Med J Aust Date: 1971-06-12 Impact factor: 7.738

3. Campylobacter cholecystitis.

Authors: A Mertens; M De Smet
Journal: Lancet Date: 1979-05-19 Impact factor: 79.321

4. Meningism associated with Campylobacter jejuni enteritis.

Authors: E P Wright
Journal: Lancet Date: 1979-05-19 Impact factor: 79.321

5. Campylobacter urinary infection.

Authors: J S Davies; J B Penfold
Journal: Lancet Date: 1979-05-19 Impact factor: 79.321

6. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors: R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal: Antimicrob Agents Chemother Date: 1978-10 Impact factor: 5.191

7. Campylobacter enteritis.

Authors: M A Karmali; P C Fleming
Journal: Can Med Assoc J Date: 1979-06-23 Impact factor: 8.262

8. Broiler chickens as potential source of Campylobacter infections in humans.

Authors: I H Grant; N J Richardson; V D Bokkenheuser
Journal: J Clin Microbiol Date: 1980-05 Impact factor: 5.948

9. Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.

Authors: T Kesado; T Hashizume; Y Asahi
Journal: Antimicrob Agents Chemother Date: 1980-06 Impact factor: 5.191

10. Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents.

Authors: A W Chow; V Patten; D Bednorz
Journal: Antimicrob Agents Chemother Date: 1978-03 Impact factor: 5.191

10 in total

1. Experimental infection of pig-tailed macaques (Macaca nemestrina) with Campylobacter cinaedi and Campylobacter fennelliae.

Authors: B M Flores; C L Fennell; L Kuller; M A Bronsdon; W R Morton; W E Stamm
Journal: Infect Immun Date: 1990-12 Impact factor: 3.441

Review 2. In vitro activity of imipenem--a review.

Authors: I Braveny
Journal: Eur J Clin Microbiol Date: 1984-10 Impact factor: 3.267

3. Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics.

Authors: C L Gaudreau; L A Lariviere; J C Lauzer; F F Turgeon
Journal: Antimicrob Agents Chemother Date: 1987-06 Impact factor: 5.191

Review 4. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors: S P Clissold; P A Todd; D M Campoli-Richards
Journal: Drugs Date: 1987-03 Impact factor: 9.546